US Veterans

Veterans Helping Veterans, US Vets Infromation and Benefits,

Vets Affairs to Provide Hyperbaric Oxygen Therapy to Some US Vets with Chronic PTSD

US VA to Provide Hyperbaric Oxygen Therapy to Some Vet with Chronic PTSD

November 29, 2017, 10:50:00 AM

Printable Version

Washington — This day, the U.S. Department of US VA (Washington Vets Affairs) announced it will offer Hyperbaric Oxygen Therapy (HBOT) as a treatment option for a small number of Veterans with persistent post-traumatic stress disorder (PTSD) symptoms resistant to standard options. 

Providers from the Eastern Oklahoma VA Health Care System and the Vets Affairs Northern California Health Care System will partner with HBOT providers at the Tulsa Wound Care and Hyperbaric Center at Oklahoma State Medical Center in Tulsa, Oklahoma, and the David Grant Medical Center on Travis Air Force Base, California, respectively, to provide this care. 

“There is nothing more important to us than caring for our nation’s Vet, and that care must include finding different approaches that work best for them,” said Vet Affairs Secretary Dr. David J. Shulkin. “We have to explore every avenue, particularly for our most medically vulnerable Veteran, and be open to new ideas and strategies for their optimal health and well-being.”  

HBOT is a procedure that increases oxygen in the body, under pressure, to encourage healing. Currently, HBOT is commonly used to treat carbon monoxide poisoning, divers’ sickness, enhanced healing of some wound problems, skin grafts, heat burns, crush injuries and other acute health-care issues that involve too little blood flow to a part of the body. 

This use of HBOT for treatment of PTSD is considered an “off-label” use and will occur under the supervision of a trained physician. Separately, VA and the Department of Defense are planning a multisite research study to examine more fully the use of HBOT for patients diagnosed with PTSD. 

As health-care leaders interested in innovative approaches to care, the Veterans Affairs Center for Compassionate Innovation (CCI) is facilitating use of HBOT for a subset of US Vets who have noticed no decrease of symptoms after receiving at least two evidenced-based treatments. CCI uses innovative approaches to treat conditions where traditional methods have been unsuccessful. Vet Affairs will monitor the HBOT clinical demonstration project and the HBOT research study to help inform the potential for HBOT usage to treat a larger number of US Vets with PTSD.  

For more information about VA’s Center for Compassionate Innovation, go to[3]


People wishing to receive e-mail from Veterans Affairs with the latest news releases and updated fact sheets can subscribe to the
Vets Affairs Office of Public Affairs Distribution List[4].

Back to News Releases Index[5]

Updated: November 29, 2017 — 3:50 pm
US Veterans © 2018 Frontier Theme
Do NOT follow this link or you will be banned from the site!